NEW YORK, May 22 – Softbank Finance of Japan and Scientia Health Group, an American incubator for biotechnology ideas, will launch Scientia Japan, which will support genomics firms in Japan, Reuters reported from Tokyo on Tuesday.

"I'm very proud to announce this. We're entering into the world of human genomics," Reuters cited Yoshitaka Kitao, president of Softbank Finance, as saying at a news conference.

Japan has only some 60 genome-related companies, Kitao reportedly said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.